Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.49 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.47 |
| ▸ | GSK3A | P49840 | 1/20 | 0.42 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.38 |
| ▸ | PIN4 | Q9Y237 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Piperazinoacetate SCHEMBL17271810 | 0.98 | SIGMAR1 (0.47) | SIGMAR1CHRM5CHRM3GSK3AGSK3B | |
| SCHEMBL8911402 | 0.98 | SIGMAR1 (0.47) | SIGMAR1CHRM5CHRM3GSK3AGSK3B | |
| Ethyl Piperazinoacetate SCHEMBL16528281 | 0.98 | SIGMAR1 (0.47) | SIGMAR1CHRM5CHRM3GSK3AGSK3B | |
| SCHEMBL8484657 | 0.98 | SIGMAR1 (0.47) | SIGMAR1CHRM5CHRM3GSK3AGSK3B | |
| SCHEMBL26091201 | 0.98 | SIGMAR1 (0.47) | SIGMAR1CHRM5CHRM3GSK3AGSK3B | |
| SCHEMBL1418858 | 0.93 | SIGMAR1 (0.54) | SIGMAR1CHRM5CHRM3GSK3AGSK3B | |
| SCHEMBL31365998 | 0.92 | SIGMAR1 (0.43) | SIGMAR1CHRM5CHRM3GSK3AGSK3B | |
| Hydrochloric Acid SCHEMBL22344162 | 0.92 | SIGMAR1 (0.52) | SIGMAR1CHRM5CHRM3GSK3AGSK3B | |
| SCHEMBL28466894 | 0.90 | SIGMAR1 (0.48) | SIGMAR1CHRM5CHRM3GSK3AGSK3B | |
| SCHEMBL4444447 | 0.90 | SIGMAR1 (0.51) | SIGMAR1CHRM5CHRM3ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005633-A | Fluorescent probe for detecting threonine tyrosine kinase and preparation method and application thereof | 五邑大学 | 2024-05-10 | — | — | CN | claimed |
| CN-104046246-B | The chemical-mechanical planarization of tungsten-containing substrate | 气体产品与化学公司 | 2016-06-15 | — | — | CN | claimed |
| US-20140273458-A1 | Chemical Mechanical Planarization for Tungsten-Containing Substrates | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-09-18 | — | — | US | claimed |
| EP-2779217-A2 | Chemical mechanical planarization for tungsten-containing substrates | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-09-17 | — | — | EP | claimed |
| CN-104046246-A | Chemical Mechanical Planarization for Tungsten-Containing Substrates | AIR PROD & CHEM | 2014-09-17 | — | — | CN | claimed |
| US-8835492-B2 | Temperature and pH sensitive block copolymer and polymeric hydrogels using the same | SUNGYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) | 2014-09-16 | — | — | US | claimed |
| CN-102838567-A | Benzenesulfonyl piperazine compounds or benzoyl piperazine compounds, preparation methods and uses thereof | SHENZHEN TONGZHOU ELECTRONIC CO LTD | 2012-12-26 | — | — | CN | claimed |
| US-20100233264-A1 | TEMPERATURE AND pH-SENSITIVE BLOCK COPOLYMER HAVING EXCELLENT SAFTY IN VIVO AND HYDROGEL AND DRUG DELIVERY SYSTEM USING THEREOF | SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) | 2010-09-16 | — | — | US | claimed |
| WO-2009031861-A2 | TEMPERATURE AND PH-SENSITIVE BLOCK COPOLYMER HAVING EXCELLENT SAFETY IN VIVO AND HYDROGEL AND DRUG DELIVERY SYSTEM USING THEREOF | SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) | 2009-03-12 | — | — | WO | claimed |
| US-20080293827-A1 | Temperature and Ph Sensitive Block Copolymer and Polymeric Hydrogels Using the Same | SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR COROPORATE COLLABORATION (KR) | 2008-11-27 | — | — | US | claimed |
| WO-2008130180-A1 | PREPARATION OF DRUG DELIVERY SYSTEMS USING PH-SENSITIVE BLOCK COPOLYMER AND THEIR APPLICATION | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2008-10-30 | — | — | WO | claimed |
| WO-2004108068-A2 | 4-[4-(4-MORPHOLINO)ANILINO]PYRIMIDINE DERIVATIVES, METHOD FOR PREPARING THEREOF AND ANTIVIRAL PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | B & C BIOPHARM CO., LTD. (KR) | 2004-12-16 | — | — | WO | claimed |
| CN-1072661-C | Novel substituted [2-(1-piperazinyl) ethoxy] methyl | UCB SA (BE) | 2001-10-10 | — | — | CN | claimed |
| CN-1215395-A | Novel substituted [2-(1-piperazinyl) ethoxy] methyl | UCB SA (BE) | 1999-04-28 | — | — | CN | claimed |
| CN-122036736-A | Pyrrolo [2,3-d ] pyrimidine derivative, synthetic method and application | 云南大学 | 2026-05-15 | — | — | CN | disclosed |
| EP-4159727-B1 | INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN | MORPHIC THERAPEUTIC INC (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20260092134-A1 | Bioreducible Poly (Beta-Amino Ester)s For siRNA Delivery | UNIV JOHNS HOPKINS (US) | 2026-04-02 | — | — | US | disclosed |
| US-4009167-A | SILVER HALIDE SOLVENTS, PHOTOGRAPHY | POLAROID CORPORATION (US) | 1977-02-22 | — | — | US | disclosed |
| US-3976647-A | PHOTOGRAPHIC SILVER HALIDE SOLVENTS | POLAROID CORPORATION (US) | 1976-08-24 | — | — | US | disclosed |
| US-3962247-A | ANGINA PECTORIS | FUJI CHEMICAL INDUSTRY CO., LTD. (JA) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100233264-A1 | TEMPERATURE AND pH-SENSITIVE BLOCK COPOLYMER HAVING EXCELLENT SAFTY IN VIVO AND HYDROGEL AND DRUG DELIVERY SYSTEM USING THEREOF | CD44, PSAT1, ALAD | SIGMAR1 1171/4885CHRM5 4340/4885CHRM3 4284/4885 |
| US-20080293827-A1 | Temperature and Ph Sensitive Block Copolymer and Polymeric Hydrogels Using the Same | LRBA, DAO, PAM | SIGMAR1 1134/4885CHRM5 2046/4885CHRM3 3014/4885 |
| US-20260092134-A1 | Bioreducible Poly (Beta-Amino Ester)s For siRNA Delivery | SLC43A1, SLC7A5, SLC7A1 | SIGMAR1 311/4885CHRM5 4707/4885CHRM3 4585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.